Helius Medical Technologies Reports Third-Party Reimbursement For PoNS; Reimbursement At $23,900, Slightly Below List Price
Portfolio Pulse from Benzinga Newsdesk
Helius Medical Technologies announced that its Portable Neuromodulation Stimulator (PoNS) device will now be covered by third-party reimbursement. This development is expected to improve patient access to the device and potentially increase sales.
May 29, 2024 | 1:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Helius Medical Technologies' PoNS device will now be covered by third-party reimbursement, which is expected to improve patient access and potentially increase sales.
The third-party reimbursement for the PoNS device is a significant development for Helius Medical Technologies. It is likely to increase patient access to the device, which could lead to higher sales and revenue growth for the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100